BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27609341)

  • 1. A Model-Based Strategy to Control the Spread of Carbapenem-Resistant Enterobacteriaceae: Simulate and Implement.
    DalBen MF; Teixeira Mendes E; Moura ML; Abdel Rahman D; Peixoto D; Alves Dos Santos S; Barcelos de Figueiredo W; Vitale Mendes P; Utino Taniguchi L; Bezerra Coutinho FA; Massad E; Levin AS
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1315-1322. PubMed ID: 27609341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
    Lee BY; Bartsch SM; Wong KF; McKinnell JA; Slayton RB; Miller LG; Cao C; Kim DS; Kallen AJ; Jernigan JA; Huang SS
    Am J Epidemiol; 2016 Mar; 183(5):471-9. PubMed ID: 26861238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active surveillance of carbapenem-resistant Enterobacteriaceae in intensive care units: Is it cost-effective in a nonendemic region?
    Ho KW; Ng WT; Ip M; You JH
    Am J Infect Control; 2016 Apr; 44(4):394-9. PubMed ID: 26698671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between infection control interventions and carbapenem-resistant Enterobacteriaceae incidence in an endemic hospital.
    Hussein K; Rabino G; Eluk O; Warman S; Reisner S; Geffen Y; Halif L; Paul M
    J Hosp Infect; 2017 Nov; 97(3):218-225. PubMed ID: 28743504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant Enterobacteriaceae carriers in acute care hospitals and postacute-care facilities: The effect of organizational culture on staff attitudes, knowledge, practices, and infection acquisition rates.
    Fedorowsky R; Peles-Bortz A; Masarwa S; Liberman D; Rubinovitch B; Lipkin V
    Am J Infect Control; 2015 Sep; 43(9):935-9. PubMed ID: 26116334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant Enterobacteriaceae at a low prevalence tertiary care center: Patient-level risk factors and implications for an infection prevention strategy.
    Doll M; Masroor N; Major Y; Fleming M; Doern C; Cooper K; Stevens M; Bearman G
    Am J Infect Control; 2017 Nov; 45(11):1286-1288. PubMed ID: 28571982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based Assessment of the Effect of Contact Precautions Applied to Surveillance-detected Carriers of Carbapenemase-producing Enterobacteriaceae in Long-term Acute Care Hospitals.
    Toth DJA; Khader K; Beams A; Samore MH
    Clin Infect Dis; 2019 Sep; 69(Suppl 3):S206-S213. PubMed ID: 31517974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging threat from carbapenem-resistant enterobacteriaceae.
    Landry J; Hurst H
    Nurs Womens Health; 2013 Dec; 17(6):519-24. PubMed ID: 24589052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider Role in Transmission of Carbapenem-Resistant Enterobacteriaceae.
    Grabowski ME; Kang H; Wells KM; Sifri CD; Mathers AJ; Lobo JM
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1329-1334. PubMed ID: 29061201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
    Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
    J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
    Friedman ND; Carmeli Y; Walton AL; Schwaber MJ
    Infect Control Hosp Epidemiol; 2017 May; 38(5):580-594. PubMed ID: 28294079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.
    Ben-David D; Masarwa S; Adler A; Mishali H; Carmeli Y; Schwaber MJ
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):802-9. PubMed ID: 24915207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities.
    Toth DJA; Khader K; Slayton RB; Kallen AJ; Gundlapalli AV; O'Hagan JJ; Fiore AE; Rubin MA; Jernigan JA; Samore MH
    Clin Infect Dis; 2017 Aug; 65(4):581-587. PubMed ID: 28472233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Success of a National Intervention in Controlling Carbapenem-resistant Enterobacteriaceae in Israel's Long-term Care Facilities.
    Ben-David D; Masarwa S; Fallach N; Temkin E; Solter E; Carmeli Y; Schwaber MJ;
    Clin Infect Dis; 2019 Mar; 68(6):964-971. PubMed ID: 29986007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active screening and interfacility communication of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital.
    Shimasaki T; Segreti J; Tomich A; Kim J; Hayden MK; Lin MY;
    Infect Control Hosp Epidemiol; 2018 Sep; 39(9):1058-1062. PubMed ID: 30022738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem-resistant Enterobacteriaceae on a cardiac surgery intensive care unit: successful measures for infection control.
    Abboud CS; de Souza EE; Zandonadi EC; Borges LS; Miglioli L; Monaco FC; Barbosa VL; Cortez D; Bianco AC; Braz A; Monteiro J
    J Hosp Infect; 2016 Sep; 94(1):60-4. PubMed ID: 27451040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing Carbapenem-Resistant Enterobacteriaceae Using the Targeted Solution Tool: A Quality Improvement Project.
    Ragonese B; Mularoni A; Valeri A; Campanella M; Corso B; Fazzina ML; Barone MA; Arena G; Lombardo R; Luca A
    J Nurs Care Qual; 2023 Jan-Mar 01; 38(1):47-54. PubMed ID: 36066885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.